Skip to main content
SpringerLink
Log in

Rust and Rupture: Atherosclerosis

  • Conference paper
  • First Online:
Pumps and Pipes

  • 1324 Accesses

Abstract

This chapter provides an overview of the pathogenesis of atherosclerosis, and integrates the latest clinical guidelines and trials into a concise and practical guide to cardiovascular risk reduction and the management of dyslipidemia. These measures form the basis for a management strategy aimed at halting the progression of atherosclerosis, stabilizing rupture-prone plaques, preventing arterial thrombosis, and improving cardiovascular prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. AHA (2009) Heart Disease and Stroke Statistics – 2009 Update. American Heart Association, Dallas, TX

    Google Scholar 

  2. Baigent C, Keech A, Kearney P, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 366:1267–1278

    Article  Google Scholar 

  3. Ford E, Li C, Pearson W, Zhao G, Mokdad A (2010) Trends in hypercholesterolemia, treatment and control among United States adults. Int J Cardiol 140:226–235

    Article  Google Scholar 

  4. Ross R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340:115–126

    Article  Google Scholar 

  5. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111:3481–3488

    Article  Google Scholar 

  6. Lavi S, McConnell J, Rihal C, Prasad A, Mathew V, Lerman L, Lerman A (2007) Local ­production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115:2715–2721

    Article  Google Scholar 

  7. Ambrose J, Tannenbaum M, Alexopoulos D, Hjemdahl-Monsen C, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V (1988) Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12:56–62

    Article  Google Scholar 

  8. Nissen S, Nicholls S, Sipahi I, Libby P, Raichlen J, Ballantyne C, Davignon J, Erbel R, Fruchart J, Tardif J, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu E (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295:1556–1565

    Article  Google Scholar 

  9. Nissen S, Tuzcu E, Schoenhagen P, Brown B, Ganz P, Vogel R, Crowe T, Howard G, Cooper C, Brodie B, Grines C, DeMaria A (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291:1071–1080

    Article  Google Scholar 

  10. Libby P, Sasiela W (2006) Plaque stabilization: Can we turn theory into evidence? Am J Cardiol 98:26P–33P

    Article  Google Scholar 

  11. Ostad M, Eggeling S, Tschentscher P, Schwedhelm E, Böger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A (2009) Flow-mediated dilation in patients with coronary artery ­disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis 205:227–232

    Article  Google Scholar 

  12. Kuklina E, Yoon P, Keenan N (2009) Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999–2006. JAMA 302:2104–2110

    Article  Google Scholar 

  13. Castelli W (1984) Epidemiology of coronary heart disease: the Framingham study. Am J Med 76:4–12

    Article  Google Scholar 

  14. Waters D, Brotons C, Chiang C, Ferrières J, Foody J, Jukema J, Santos R, Verdejo J, Messig M, McPherson R, Seung K, Tarasenko L (2009) Lipid Treatment Assessment Project 2: a ­multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation 120:28–34

    Article  Google Scholar 

  15. Corti M, Guralnik J, Salive M, Harris T, Ferrucci L, Glynn R, Havlik R (1997) Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 126:753–760

    Google Scholar 

  16. National Cholesterol Education Program (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421

    Google Scholar 

  17. Wilson P, Anderson K, Castelli W (1991) Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med 90:11–16

    Article  Google Scholar 

  18. Gordon D, Probstfield J, Garrison R, Neaton J, Castelli W, Knoke J, Jacobs DJ, Bangdiwala S, Tyroler H (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8–15

    Article  Google Scholar 

  19. Brugts J, Yetgin T, Hoeks S, Gotto A, Shepherd J, Westendorp R, de Craen A, Knopp R, Nakamura H, Ridker P, van Domburg R, Deckers J (2009) The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 338:b2376

    Article  Google Scholar 

  20. Ballantyne C, Raichlen J, Nicholls S, Erbel R, Tardif J, Brener S, Cain V, Nissen S (2008) Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden. Circulation 117:2458–2466

    Article  Google Scholar 

  21. Smilde T, van Wissen S, Wollersheim H, Trip M, Kastelein J, Stalenhoef A (2001) Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 357:577–581

    Article  Google Scholar 

  22. Taylor A, Kent S, Flaherty P, Coyle L, Markwood T, Vernalis M (2002) ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 106:2055–2060

    Article  Google Scholar 

  23. Crouse JR, Raichlen J, Riley W, Evans G, Palmer M, O’Leary D, Grobbee D, Bots M (2007) Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial. JAMA 297:1344–1353

    Article  Google Scholar 

  24. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22

    Article  Google Scholar 

  25. Ridker P, Danielson E, Fonseca F, Genest J, Gotto AM Jr., Kastelein J, Koenig W, Libby P, Lorenzatti A, MacFadyen J, Nordestgaard B, Shepherd J, Willerson J, Glynn R (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207

    Article  Google Scholar 

  26. Cannon C, Braunwald E, McCabe C, Rader D, Rouleau J, Belder R, Joyal S, Hill K, Pfeffer M, Skene A (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:495–504

    Article  Google Scholar 

  27. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352:1425–1435

    Article  Google Scholar 

  28. Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J (2005) High-dose atorvastatin vs usual-dose ­simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 294:2437–2445

    Article  Google Scholar 

  29. Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB Jr., Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr., Stone NJ (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239

    Article  Google Scholar 

  30. Smith SJ, Allen J, Blair S, Bonow R, Brass L, Fonarow G, Grundy S, Hiratzka L, Jones D, Krumholz H, Mosca L, Pasternak R, Pearson T, Pfeffer M, Taubert K (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic ­vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113:2363–2372

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, 6565 Fannin, M.S. A-601, Houston, TX, 77030, USA

    Christie M. Ballantyne

Authors
  1. Justin T. Saunders
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christie M. Ballantyne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christie M. Ballantyne .

Editor information

Editors and Affiliations

  1. Methodist DeBakey Heart &, Vascular Center, The Methodist Hospital, 6550 Fannin Street, Houston, 77030, Texas, USA

    Mark G. Davies

  2. Methodist DeBakey Heart &, Vascular Center, The Methodist Hospital, 6550 Fannin Street, Houston, 77030, Texas, USA

    Alan B. Lumsden

  3. Wells & Materials Division, ExxonMobil Upstream Research Company, Houston, Texas, USA

    William E. Kline

  4. Dept. Computer Science, University of Houston, Calhoun Rd. 4800, Houston, 77204-3475, Texas, USA

    Ioannis Kakadiaris

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this paper

Cite this paper

Saunders, J.T., Ballantyne, C.M. (2011). Rust and Rupture: Atherosclerosis. In: Davies, M., Lumsden, A., Kline, W., Kakadiaris, I. (eds) Pumps and Pipes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6012-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-6012-2_8

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-6011-5

  • Online ISBN: 978-1-4419-6012-2

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation